Xtant Medical to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
BELGRADE, Mont., Sept. 4, 2025 /PRNewswire/ — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic,
Xtant Medical to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
BELGRADE, Mont. , Sept. 4, 2025 /PRNewswire/ — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions
Xtant Medical Reports Second Quarter 2025 Financial Results
Total Revenue of $35.4 Million Increased 18% Year-over-Year Delivers Positive Net Income, Adjusted EBITDA and Operating Cash Flow Raises FY25 Revenue Guidance to $131-$135 Million
Xtant Medical to Attend the CG 45th Annual Growth Conference
BELGRADE, Mont. , Aug. 6, 2025 /PRNewswire/ — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for
Xtant Medical to Announce Second Quarter 2025 Financial Results on August 12, 2025
BELGRADE, Mont. , Aug. 5, 2025 /PRNewswire/ — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for
Xtant Medical Announces Definitive Agreements for the Sale of its Coflex® and CoFix® Spinal Implants and All OUS Businesses to Companion Spine
Transaction expected to facilitate enhanced focus on Xtant’s core businesses Total consideration of approximately $19.2 million allows Xtant to reduce outstanding debt and improve liquidity
Xtant Medical Announces the Launch of OsteoFactor Pro™
Allogeneic Growth Factor Solution to Accelerate Bone Repair BELGRADE, Mont. , May 28, 2025 /PRNewswire/ — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global
Xtant Medical Reports First Quarter 2025 Financial Results
Revenue Increases 18% Year-over-Year Delivers Positive Net Income and $1.3 Million in Operating Cash Flow Increases 2025 Revenue Guidance to $127 Million to $131 Million
Xtant Medical to Issue First Quarter 2025 Financial Results on May 12, 2025
BELGRADE, Mont. , May 6, 2025 /PRNewswire/ — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions
Xtant Medical Launches Trivium™ Advanced Bone Graft for Superior Performance
BELGRADE, Mont. , April 23, 2025 /PRNewswire/ — Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the
Xtant Medical Announces Secondary Private Sale of Existing Shares by OrbiMed and Preliminary First Quarter 2025 Revenue Growth of 18% to 19%
Healthcare Focused Long-term Investors Support Strategic Vision Accelerating Shift to Higher-Margin Orthobiologics Supported by New Product Launches BELGRADE, Mont. , April 16, 2025 /PRNewswire/ —